{"data":{"ticker":"RXRX","name":"RECURSION PHARMACEUTICALS, INC.","cik":"0001601830","quarterly":[{"frame":"CY2023Q3","end":"2023-09-30","revenue":10533000,"netIncome":-93017000,"epsDiluted":-0.43,"fiscalPeriod":"Q3 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2023Q4","end":"2023-12-31","revenue":10891000,"netIncome":-92996000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2023","fiscalYear":"FY 2023"},{"frame":"CY2024Q1","end":"2024-03-31","revenue":13794000,"netIncome":-91373000,"epsDiluted":-0.39,"fiscalPeriod":"Q1 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q2","end":"2024-06-30","revenue":14417000,"netIncome":-97540000,"epsDiluted":-0.4,"fiscalPeriod":"Q2 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q3","end":"2024-09-30","revenue":26082000,"netIncome":-95842000,"epsDiluted":-0.34,"fiscalPeriod":"Q3 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2024Q4","end":"2024-12-31","revenue":4546000,"netIncome":-178906000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2024","fiscalYear":"FY 2024"},{"frame":"CY2025Q1","end":"2025-03-31","revenue":14745000,"netIncome":-202487000,"epsDiluted":-0.5,"fiscalPeriod":"Q1 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q2","end":"2025-06-30","revenue":19223000,"netIncome":-171897000,"epsDiluted":-0.41,"fiscalPeriod":"Q2 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q3","end":"2025-09-30","revenue":5175000,"netIncome":-162253000,"epsDiluted":-0.36,"fiscalPeriod":"Q3 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2025Q4","end":"2025-12-31","revenue":35538000,"netIncome":-108122000,"epsDiluted":null,"derived":true,"fiscalPeriod":"Q4 FY 2025","fiscalYear":"FY 2025"},{"frame":"CY2026Q1","end":"2026-03-31","revenue":6472000,"netIncome":-117504000,"epsDiluted":-0.22,"fiscalPeriod":"Q1 FY 2026","fiscalYear":"FY 2026"},{"frame":"CY2026Q2","end":"2026-06-30","revenue":7670000,"netIncome":-131005000,"epsDiluted":-0.25,"fiscalPeriod":"Q2 FY 2026","fiscalYear":"FY 2026"}],"annual":[{"frame":"CY2020","end":"2020-12-31","fiscalYear":"FY 2020","revenue":3962000,"netIncome":-87006000,"operatingCashFlow":-45399000,"capex":5831000,"buybacks":null,"dividends":null},{"frame":"CY2021","end":"2021-12-31","fiscalYear":"FY 2021","revenue":10178000,"netIncome":-186479000,"operatingCashFlow":-158614000,"capex":39798000,"buybacks":null,"dividends":null},{"frame":"CY2022","end":"2022-12-31","fiscalYear":"FY 2022","revenue":39843000,"netIncome":-239476000,"operatingCashFlow":-83524000,"capex":37059000,"buybacks":null,"dividends":null},{"frame":"CY2023","end":"2023-12-31","fiscalYear":"FY 2023","revenue":44575000,"netIncome":-328066000,"operatingCashFlow":-287780000,"capex":11955000,"buybacks":null,"dividends":null},{"frame":"CY2024","end":"2024-12-31","fiscalYear":"FY 2024","revenue":58839000,"netIncome":-463661000,"operatingCashFlow":-359174000,"capex":13695000,"buybacks":null,"dividends":null},{"frame":"CY2025","end":"2025-12-31","fiscalYear":"FY 2025","revenue":74681000,"netIncome":-644759000,"operatingCashFlow":-371808000,"capex":6469000,"buybacks":null,"dividends":null}],"latest":{"end":"2026-06-30","cash":545683000,"debt":null,"equity":915003000,"assets":1212668000,"sharesOutstanding":535342170,"sharesDate":"2026-07-31","form":"10-Q"},"source":"SEC XBRL companyfacts, values as filed in USD","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx"},"updatedAt":"2026-10-29T05:23:26.710Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/rxrx","meta":{"source":"SEC","sourceAttribution":"Financial statement data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}